Skip to main content
. 2009 Oct 8;158(5):1276–1284. doi: 10.1111/j.1476-5381.2009.00442.x

Figure 5.

Figure 5

Electrophoretic mobility shift assay for NF-κB in cells from coronary heart disease (CHD) patients. In (A), monocytes and monocyte-derived macrophages (MDMs) from smoker and non-smoker CHD patients stimulated by phorbol-12-myristate 13-acetate (PMA) (10−6 M) or lipopolysaccharide (500 ng·mL−1) for 1 h. In (B), effects of rosiglitazone (rosi; 5 × 10−6 M) and GW9662 (GW; 10−6 M) on monocytes from smoker and non-smoker CHD patients stimulated by PMA. In (C), effects of rosiglitazone (rosi; 5 × 10−6 M) and GW9662 (GW; 10−6 M) on MDM from smoker and non-smoker CHD patients stimulated by PMA. Each gel is representative of two others.